Literature DB >> 33193956

Continuous venous hemodialysis integrated to the ECMO circuit in critically ill patient with COVID-19, a case report in Morocco.

Anass Mounir1, Saara Lamghari1, Amine Raja1, Khalil Allali1, Sara Chebbar1, Basma Buri1, Yasmine Mahdar1, Chafik El Kettani1, Benyounes Ramdani2, Youssef Ettaoumi3, Ghali Benouna4, Lahoucine Barrou1.   

Abstract

Novel coronavirus 2019 (COVID-19) is a severe respiratory infection leading to acute respiratory distress syndrome [ARDS] accounting for thousands of cases and deaths across the world. Several alternatives in treatment options have been assessed and used in this patient population. However, when mechanical ventilation and prone positioning are unsuccessful, venovenous extracorporeal membrane oxygenation [VV-ECMO] may be used. We present a case of a 62-year-old female, diabetic, admitted to the intensive care unit with fever, flu-like symptoms and a positive COVID-19 test. Ultimately, she worsened on mechanical ventilation and prone positioning and required VV-ECMO. The use of VV-ECMO in COVID-19 infected patients is still controversial. While some studies have shown a high mortality rate despite aggressive treatment, such as in our case, the lack of large sample size studies and treatment alternatives places healthcare providers against a wall without options in patients with severe refractory ARDS due to COVID-19. Copyright: Anass Mounir et al.

Entities:  

Keywords:  ARDS; COVID-19; ECMO; hemodialysis

Mesh:

Substances:

Year:  2020        PMID: 33193956      PMCID: PMC7608773          DOI: 10.11604/pamj.supp.2020.35.141.25332

Source DB:  PubMed          Journal:  Pan Afr Med J


  7 in total

1.  Extracorporeal membrane oxygenation in COVID-19.

Authors:  Jacek Smereka; Mateusz Puslecki; Kurt Ruetzler; Krzysztof J Filipiak; Milosz Jaguszewski; Jerzy R Ladny; Lukasz Szarpak
Journal:  Cardiol J       Date:  2020-04-14       Impact factor: 2.737

2.  Extracorporeal Life Support Organization Registry International Report 2016.

Authors:  Ravi R Thiagarajan; Ryan P Barbaro; Peter T Rycus; D Michael Mcmullan; Steven A Conrad; James D Fortenberry; Matthew L Paden
Journal:  ASAIO J       Date:  2017 Jan/Feb       Impact factor: 2.872

3.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

Review 4.  Continuous renal replacement therapy during extracorporeal membrane oxygenation: why, when and how?

Authors:  Marlies Ostermann; Michael Connor; Kianoush Kashani
Journal:  Curr Opin Crit Care       Date:  2018-12       Impact factor: 3.687

5.  COVID-19, ECMO, and lymphopenia: a word of caution.

Authors:  Brandon Michael Henry
Journal:  Lancet Respir Med       Date:  2020-03-13       Impact factor: 30.700

6.  Timing of ECMO Initiation Impacts Survival in Influenza-Associated ARDS.

Authors:  Desiree A Steimer; Omar Hernandez; David P Mason; Gary S Schwartz
Journal:  Thorac Cardiovasc Surg       Date:  2018-05-01       Impact factor: 1.827

7.  Toward Precision Delivery of ECMO in COVID-19 Cardiorespiratory Failure.

Authors:  Vasileios Zochios; Daniel Brodie; Ken Kuljit Parhar
Journal:  ASAIO J       Date:  2020-07       Impact factor: 3.826

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.